Company

About

BioGeometry

BioGeometry

4343 Shallowford Road Ste E6

BioGeometry is an AI-driven biotech dedicated to developing next-generation, programmable protein medicines. We aim to solve the high cost, long lead time, low success rate problems for traditional macromolecular theraputics through the combination of geometric deep learning, structural biology, immunology, and synthetic biology. We enjoy talents from renowned pharmaceutical companies, top-tier AI and bio labs worldwide.

Georgia Genomics and Bioinformatics Core, University of Georgia

Georgia Genomics and Bioinformatics Core, University of Georgia

Athens, Georgia, United States

The Georgia Genomics and Bioinformatics Core (GGBC) is the University of Georgia (UGA) core laboratory for nucleic acid sequencing and bioinformatics. Theirmission includes research support, education, and training. Theirservices are available to university and industry researchers.Theirservices encompass the range of genomic techniques and applications, sequencing technologies, and bioinformatics analyses. GGBC operates multiple platforms for short-, long-, and single-molecule sequencing reads (i.e., Illumina MiSeq and NextSeq, PacBio Sequel, and Oxford Nanopore MinIon). Theyalso write letters of support (LOS) to offer theircapabilities and expertise for grant applications submitted to funding agencies.

Institute of Bioinformatics--University of Georgia

Institute of Bioinformatics--University of Georgia

Athens, Georgia, United States

The Institute of Bioinformatics's mission is to facilitate cutting-edge interdisciplinary research in bioinformatics/computational biology and its application. We train graduate students to tackle complex biological problems which utilize omics or other complex data types.

Lectenz Bio

Lectenz Bio

Athens, Georgia, United States

Lectenz Bio is developing novel products that employ our unique Lectenz® reagents and GlycoSense™ technology, to speed up and simplify the detection and discovery of disease biomarkers. These products enable targeting glycan biomarkers of clinical significance for investigation and leveraging them for advancing human health. Glycan-based biomarkers are particularly important for disease diagnosis and clinical treatment, yet their discovery and detection is challenging, due to the lack of glycan-specific reagents and tools. We are meeting this important need by developing innovative technologies in the glycosciences that will advance critical research and clinical applications. We are excited about helping to improve human health in this underexploited area. The company’s mission is to develop technologies that enable novel glycoscience applications, provide services that enhance glycan biomarker detection, and deliver tools that advance research and clinical applications.